These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


554 related items for PubMed ID: 29364482

  • 1. MiR-101 promotes nasopharyngeal carcinoma cell apoptosis through inhibiting Ras/Raf/MEK/ERK signaling pathway.
    Wu RS, Qiu EH, Zhu JJ, Wang JR, Lin HL.
    Eur Rev Med Pharmacol Sci; 2018 Jan; 22(1):150-157. PubMed ID: 29364482
    [Abstract] [Full Text] [Related]

  • 2. MiR-16 inhibits pituitary adenoma cell proliferation via the suppression of ERK/MAPK signal pathway.
    Wang DW, Wang YQ, Shu HS.
    Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1241-1248. PubMed ID: 29565480
    [Abstract] [Full Text] [Related]

  • 3. MiR-203 over-expression promotes prostate cancer cell apoptosis and reduces ADM resistance.
    Chen LZ, Ding Z, Zhang Y, He ST, Wang XH.
    Eur Rev Med Pharmacol Sci; 2018 Jun; 22(12):3734-3741. PubMed ID: 29949147
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of miR-221 influences bladder cancer cell proliferation and apoptosis.
    Liu H, Chang JK, Hou JQ, Zhao ZH, Zhang LD.
    Eur Rev Med Pharmacol Sci; 2017 Jul; 21(14):3193-3199. PubMed ID: 28770966
    [Abstract] [Full Text] [Related]

  • 5. MiR-182 affects renal cancer cell proliferation, apoptosis, and invasion by regulating PI3K/AKT/mTOR signaling pathway.
    Fu JH, Yang S, Nan CJ, Zhou CC, Lu DQ, Li S, Mu HQ.
    Eur Rev Med Pharmacol Sci; 2018 Jan; 22(2):351-357. PubMed ID: 29424922
    [Abstract] [Full Text] [Related]

  • 6. miR-181a down-regulates MAP2K1 to enhance adriamycin sensitivity in leukemia HL-60 cells.
    Wang JJ, Yu JP.
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2497-2504. PubMed ID: 30964176
    [Abstract] [Full Text] [Related]

  • 7. Up-regulation of microRNA-497 inhibits the proliferation, migration and invasion but increases the apoptosis of multiple myeloma cells through the MAPK/ERK signaling pathway by targeting Raf-1.
    Ye CY, Zheng CP, Ying WW, Weng SS.
    Cell Cycle; 2018 Mar; 17(24):2666-2683. PubMed ID: 30382763
    [Abstract] [Full Text] [Related]

  • 8. LINC00114 promoted nasopharyngeal carcinoma progression and radioresistance in vitro and in vivo through regulating ERK/JNK signaling pathway via targeting miR-203.
    Han YY, Liu K, Xie J, Li F, Wang Y, Yan B.
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2491-2504. PubMed ID: 32196600
    [Abstract] [Full Text] [Related]

  • 9. MiR-155 regulates lymphoma cell proliferation and apoptosis through targeting SOCS3/JAK-STAT3 signaling pathway.
    Li XD, Li XM, Gu JW, Sun XC.
    Eur Rev Med Pharmacol Sci; 2017 Nov; 21(22):5153-5159. PubMed ID: 29228427
    [Abstract] [Full Text] [Related]

  • 10. MircoRNA-629 promotes proliferation, invasion and migration of nasopharyngeal carcinoma through targeting PDCD4.
    Zheng YQ, Bai YF, Yang S, Cui YR, Wang YP, Hu WL.
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):207-216. PubMed ID: 30657562
    [Abstract] [Full Text] [Related]

  • 11. miR‑101 regulates the cell proliferation and apoptosis in diffuse large B‑cell lymphoma by targeting MEK1 via regulation of the ERK/MAPK signaling pathway.
    Huang Y, Zou Y, Lin L, Ma X, Zheng R.
    Oncol Rep; 2019 Jan; 41(1):377-386. PubMed ID: 30365139
    [Abstract] [Full Text] [Related]

  • 12. MicroRNA-124-3p inhibits the growth and metastasis of nasopharyngeal carcinoma cells by targeting STAT3.
    Xu S, Zhao N, Hui L, Song M, Miao ZW, Jiang XJ.
    Oncol Rep; 2016 Mar; 35(3):1385-94. PubMed ID: 26707908
    [Abstract] [Full Text] [Related]

  • 13. MiR-155 affects renal carcinoma cell proliferation, invasion and apoptosis through regulating GSK-3β/β-catenin signaling pathway.
    Wei RJ, Zhang CH, Yang WZ.
    Eur Rev Med Pharmacol Sci; 2017 Nov; 21(22):5034-5041. PubMed ID: 29228417
    [Abstract] [Full Text] [Related]

  • 14. Hsa_circ_001193 regulates proliferation and apoptosis of nasopharyngeal carcinoma cells through targeting mir-496.
    Ke KJ, Wang CY, Li P, Huang XW, Zhang SL, Li X, Cui XF.
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3069-3076. PubMed ID: 32271424
    [Abstract] [Full Text] [Related]

  • 15. MiR-214 Mediates Cell Proliferation and Apoptosis of Nasopharyngeal Carcinoma Through Targeting Both WWOX and PTEN.
    Han JB, Huang ML, Li F, Yang R, Chen SM, Tao ZZ.
    Cancer Biother Radiopharm; 2020 Oct; 35(8):615-625. PubMed ID: 32101017
    [Abstract] [Full Text] [Related]

  • 16. Activation of miR-21 by STAT3 induces proliferation and suppresses apoptosis in nasopharyngeal carcinoma by targeting PTEN gene.
    Ou H, Li Y, Kang M.
    PLoS One; 2014 Oct; 9(11):e109929. PubMed ID: 25365510
    [Abstract] [Full Text] [Related]

  • 17. MicroRNA-185 inhibits cell proliferation while promoting apoptosis and autophagy through negative regulation of TGF-β1/mTOR axis and HOXC6 in nasopharyngeal carcinoma.
    Cheng JZ, Chen JJ, Wang ZG, Yu D.
    Cancer Biomark; 2018 Oct; 23(1):107-123. PubMed ID: 29991129
    [Abstract] [Full Text] [Related]

  • 18. miR-543 promoted the cell proliferation and invasion of nasopharyngeal carcinoma by targeting the JAM-A.
    Jiang X, Dai B, Feng L.
    Hum Cell; 2019 Oct; 32(4):477-486. PubMed ID: 31428943
    [Abstract] [Full Text] [Related]

  • 19. Regulatory Mechanism of lncRNA CTBP1-AS2 in Nasopharyngeal Carcinoma Cell Proliferation and Apoptosis via the miR-140-5p/BMP2 Axis.
    Huang B, Li Y, Deng Z, Lan G, Si Y, Zhou Q.
    Protein Pept Lett; 2022 Oct; 29(7):621-630. PubMed ID: 35894463
    [Abstract] [Full Text] [Related]

  • 20. Targeting of GSK-3β by miR-214 to facilitate gastric cancer cell proliferation and decrease of cell apoptosis.
    Li HL, Liang S, Cui JH, Han GY.
    Eur Rev Med Pharmacol Sci; 2018 Jan; 22(1):127-134. PubMed ID: 29364479
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 28.